Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Interactive Tools
Sponsored
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Andrea Sitlinger, MD, Duke University Cancer Institute
home
Articles
Advice for Community Oncologists on Treating HCL
June 30th 2020
Treatments for Relapsed/Refractory HCL in Pipeline
June 30th 2020
The Role of CD22-targeted Immunotoxins in HCL
June 30th 2020
Landscape Change in the Treatment of Relapsed/Refractory HCL
June 30th 2020
Historical Treatment for Relapsed/Refractory HCL
June 30th 2020
When to Not Use Combination and the Need for Bone Marrow Biopsy in HCL
June 30th 2020
Combination First-line Therapy in Hairy Cell Leukemia
June 30th 2020
Determining When to Treat and First-Line Therapy for HCL
June 30th 2020
Differential Diagnosis and Molecular Tests in Identifying HCL
June 30th 2020
Signs and Tests for Diagnosis and Prognosis of HCL
June 30th 2020
Molecular Genetic Changes for Hairy Cell Leukemia
June 30th 2020
Introduction and Epidemiology of Hairy Cell Leukemia
June 30th 2020